Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced case study data, which showed that Auryxia (ferric citrate) lowered and maintained serum phosphorus ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE